Dr James Duboff is a seasoned professional in the field of genomics and precision medicine, currently serving as the Strategic Partnerships Director at Genomics England. With a strong academic background in Biochemistry (MBiochem, University of Oxford) and Genetics (PhD, University of Cambridge) paired with industry expertise in business development and strategic planning, James has a proven track record of driving collaborations and partnerships within the healthcare and life sciences industries.
Throughout his career, James has been at the forefront of advancing cutting-edge technologies and therapies, particularly in R&D leadership within global biopharmaceuticals (GSK) and consumer healthcare (P&G) organisations, as well as UK-based start up and scale ups. His deep understanding of the industry landscape, coupled with his ability to forge key relationships with stakeholders, has been instrumental in driving innovation and accelerating the development of novel treatments.
At Genomics England, James plays a pivotal role in identifying and cultivating strategic partnerships that further the organization's mission of leveraging genomics to transform healthcare delivery. His expertise in navigating complex regulatory environments and his keen business acumen make him a valuable asset in driving forward the adoption of advanced therapies.
With a passion for driving positive change in healthcare through innovation, James is committed to advancing the field of cell and gene therapies. His insights and communication skills make him a sought-after speaker and thought leader in the industry, and he is dedicated to sharing his knowledge and expertise to inspire others in the pursuit of groundbreaking advancements in healthcare.